Gelonghui reported on December 19 that Xiangyu Medical (688626.SH) held the first meeting of the third Board of Directors and the first meeting of the third Supervisory Board on December 19, 2024. During these meetings, they reviewed and approved the proposal regarding the completion of the company's fundraising project and the permanent supplementation of working capital with the remaining funds from all completed fundraising projects. The company agreed to conclude the fundraising project "Asia Vets Rehabilitation Equipment (Southwest) Sales Center Project" from its initial public offering funds, and to permanently supplement working capital with the remaining funds totaling 36.1245 million yuan (including interest income after deducting handling fees, cash management income, etc., the actual amount is based on the balance of the dedicated fundraising account on the day the funds are transferred) for the company's ongoing production and operational activities.